Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Lisa M. Morris is active.

Publication


Featured researches published by Lisa M. Morris.


Current HIV Research | 2010

Stability of dried blood spots for HIV-1 drug resistance analysis.

Anna C. Hearps; Claire Ryan; Lisa M. Morris; Megan M. Plate; Vicki Greengrass; Suzanne M. Crowe

The wide scale application of dried blood spots (DBS) as a collection tool for low-cost HIV drug resistance testing requires a greater understanding of the accuracy of DBS for genotype analysis and the stability of DBS under various environmental conditions. Analysis of a 50microl DBS via a single amplicon, nested PCR-based in-house assay (the Burnet genotyping assay) showed an average nucleotide concordance of 98.9% with plasma samples, although only 65% of nucleotide mixtures detected in plasma were also detected within DBS. The analysis of three DBS resulted in the detection of a greater number of nucleotide mixtures (72 and 109 mixtures detected within one and three DBS, respectively, n=10). Two DBS extraction protocols (silica particle; NucliSENS, bioMerieux and spin column extraction; High Pure, Roche) were assessed and found to be equivalent (79% and 84% recovery success respectively, n=19). FTA Elute paper (Whatman) was an inferior DBS collection medium compared to Whatman 903 paper. DBS appeared relatively tolerant to multiple freeze/thaw cycles, with 79% of DBS subjected to ten freeze/thaw cycles successfully amplified compared to 93% of DBS defrosted once (n=14). High temperature (37 degrees C) and high humidity (>90%) substantially impaired DBS recovery within two weeks of storage (38%, n=8), whilst storage at -20 degrees C or 4 degrees C adequately preserved DBS for this period (100% recovery, n=8). Therefore, whilst DBS are suitable for HIV drug resistance surveillance, the use of multiple DBS may be required to ensure accurate detection of minor HIV quasispecies and short-term storage of samples at either 4 degrees C or -20 degrees C is recommended.


Journal of Clinical Microbiology | 2009

Evaluation of the Cavidi ExaVir Load Assay (Version 3) for Plasma Human Immunodeficiency Virus Type 1 Load Monitoring

Vicki Greengrass; Megan M. Plate; Pauline M. Steele; Justin T. Denholm; Catherine L. Cherry; Lisa M. Morris; Anna C. Hearps; Suzanne M. Crowe

ABSTRACT We evaluated the new low-cost ExaVir Load (version 3) reverse transcriptase viral load assay against the Roche Cobas Amplicor assay. Results for samples tested using the reverse transcriptase assay correlated well with those obtained with the Roche assay (r = 0.85; n = 202). The version 3 reverse transcriptase assay shows improved sensitivity compared to the previous version.


Journal of Acquired Immune Deficiency Syndromes | 2009

Assessment of the low cost Cavidi ExaVir™ Load assay for monitoring HIV viral load in pediatric and adult patients

Vicki Greengrass; Barbera Lohman; Lisa M. Morris; Megan M. Plate; Pauline M. Steele; Judd L. Walson; Suzanne M. Crowe

Background:Viral load (VL) is a critical marker for monitoring HIV disease progression and response to antiretroviral therapy. In resource-constrained settings, there is a need for a simple and inexpensive assay to monitor infected adults and children. Methods:We compared versions 2 and 3 of the ExaVir Load assay, Cavidi AB (HIV RT) with the Roche, COBAS Amplicor HIV-1 Monitor assay (HIV RNA) for quantifying HIV VL. Results:The HIV RT version 2 assay showed good sensitivity with detection in 94% of samples with HIV RNA >1000 copies per milliliter. Adult samples were tested using HIV RT version 2 (n = 35) and version 3 (n = 23) assays with plasma volumes of 1 mL (recommended), 0.5 mL and 0.25 mL in comparison with HIV RNA. The HIV RT and HIV RNA assay results were comparable when tested using different volumes. Comparison of results from pediatric samples (n = 27), tested using 1 mL and a smaller volume by HIV RT version 2 were not significantly different. Conclusions:The HIV RT assay was comparable to the HIV RNA assay with sensitivity approaching that of HIV RNA. Smaller volumes than the recommended 1 mL can be used, improving utility of this assay for pediatric monitoring.


Laryngoscope | 2014

Are prophylactic antibiotics useful in the management of facial fractures

Lisa M. Morris; Robert M. Kellman

BACKGROUND Surgeons operating in the head and neck commonly treat facial fractures; however, the role of prophylactic antibiotics remains controversial. Facial fractures vary in location and severity and can span the range of wound classifications including clean, clean contaminated, contaminated, and dirty/infected. It is clear that actively infected facial fractures should be treated with therapeutic antibiotics; however, there is widespread variability in the use, type, timing, and duration of prophylactic antibiotic use in practice today. In an era of increased antibiotic resistance, as well as greater focus on evidence-based medicine and reducing health care costs, it is important to review the current evidence for the role of prophylactic antibiotics in facial fractures.


Viral Immunology | 2009

Evaluation of the blood stabilizers TransFix and Cyto-Chex BCT for low-cost CD4 T-cell methodologies.

Megan M. Plate; Raul Louzao; Pauline M. Steele; Vicki Greengrass; Lisa M. Morris; Jenny Lewis; David James Barnett; Dominic Warrino; Anna C. Hearps; Thomas N. Denny; Suzanne M. Crowe

TransFix(TM) and Cyto-Chex((R)) BCT (blood collection tube) reagents have been shown to maintain whole blood integrity for delayed immunophenotyping by flow cytometry. We evaluated the ability of these blood-stabilizing reagents to preserve HIV-seropositive blood for delayed CD4(+) T-cell quantification utilizing the Dynal((R)) Biotech T4 Quant Kit. TransFix was added to EDTA-anticoagulated whole blood and tested at a 1:10 dilution over 7 d using the Dynal (n = 21) manual method. Compared to baseline analysis, a significant decrease in mean CD4(+) counts was observed over time. Cyto-Chex BCT-preserved samples (n = 20) were tested for CD4(+) counts by Dynal over 7 d, with storage at varying temperatures: room temperature (21 degrees C), 37 degrees C, and 37 degrees C with intermittent storage at 42 degrees C. A significant decline in mean CD4(+) counts was observed in samples at all temperatures compared to baseline (p < 0.05). Increases in temperature to and above 37 degrees C resulted in a greater decline in mean CD4(+) counts over time. Our findings indicated that neither TransFix or Cyto-Chex BCT was a suitable blood stabilizer when used for delayed CD4(+) quantification with a low-cost manual CD4(+) bead-based method.


Otolaryngology-Head and Neck Surgery | 2009

Removal of hypopharyngeal foreign bodies with the GlideScope video laryngoscope

Lisa M. Morris; Mark K. Wax; Stephen M. Weber

The removal of airway foreign bodies (FBs) is a common procedure performed by otolaryngologists. The extraction of hypopharyngeal FBs via direct laryngoscopy is safe and expeditious but typically requires general anesthesia because of significant tongue base retraction and neck extension. In cases in which the FB prevents access to the airway or in the patient with limited cervical spine mobility, this approach is greatly limited. We have successfully used the GlideScope video laryngoscope (GVL) (Verathon Inc, Bothell, WA) for rapid and safe hypopharyngeal FB removal without the need for tracheal intubation or significant neck extension.


PLOS ONE | 2012

Mouse Middle Ear Ion Homeostasis Channels and Intercellular Junctions

Lisa M. Morris; Jacqueline M. DeGagne; J. Beth Kempton; Frances A. Hausman; Dennis R. Trune

Hypothesis The middle ear contains homeostatic mechanisms that control the movement of ions and fluids similar to those present in the inner ear, and are altered during inflammation. Background The normal middle ear cavity is fluid-free and air-filled to allow for effective sound transmission. Within the inner ear, the regulation of fluid and ion movement is essential for normal auditory and vestibular function. The same ion and fluid channels active in the inner ear may have similar roles with fluid regulation in the middle ear. Methods Middle and inner ears from BALB/c mice were processed for immunohistochemistry of 10 specific ion homeostasis factors to determine if similar transport and barrier mechanisms are present in the tympanic cavity. Examination also was made of BALB/c mice middle ears after transtympanic injection with heat-killed Haemophilus influenza to determine if these channels are impacted by inflammation. Results The most prominent ion channels in the middle ear included aquaporins 1, 4 and 5, claudin 3, ENaC and Na+,K+-ATPase. Moderate staining was found for GJB2, KCNJ10 and KCNQ1. The inflamed middle ear epithelium showed increased staining due to expected cellular hypertrophy. Localization of ion channels was preserved within the inflamed middle ear epithelium. Conclusions The middle ear epithelium is a dynamic environment with intrinsic mechanisms for the control of ion and water transport to keep the middle ear clear of fluids. Compromise of these processes during middle ear disease may underlie the accumulation of effusions and suggests they may be a therapeutic target for effusion control.


Facial Plastic Surgery Clinics of North America | 2016

Nonsyndromic Craniosynostosis and Deformational Head Shape Disorders

Lisa M. Morris

This article provides an overview of etiology, epidemiology, pathology, diagnosis, and treatment of nonsyndromic craniosynostosis, including sagittal, metopic, coronal, lambdoid, and complex synostosis. Detailed discussion is presented regarding indications for surgical intervention and management options, including frontoorbital advancement, cranial vault reconstruction, endoscopic strip craniectomy, spring-assisted strip craniectomy, and cranial vault distraction osteogenesis. Deformational plagiocephaly is also presented with treatment options including repositioning, physical therapy, and helmet therapy.


Journal of Law Medicine & Ethics | 2016

Including Language Access into Medicaid ACO Design.

Rachel Gershon; Lisa M. Morris; Warren J. Ferguson

Quality health care relies upon communication in a patients preferred language. Language access in health care occurs when individuals are: (1) Welcomed by providers regardless of language ability; and (2) Offered quality language services as part of their care. Federal law generally requires access to health care and quality language services for deaf and Limited English Proficient (LEP) patients in health care settings, but these patients still find it hard to access health care and quality language services. Meanwhile, several states are implementing Medicaid Accountable Care Organization (ACO) initiatives to reduce health care costs and improve health care quality. Alternative payment methods used in these initiatives can give Accountable Care Organizations more flexibility to design linguistically accessible care, but they can also put ACOs at increased financial risk for the cost of care. If these new payment methods do not account for differences in patient language needs, ACO initiatives could have the unintended consequence of rewarding ACOs who do not reach out to deaf and LEP communities or offer quality language services. We reviewed public documents related to Medicaid ACO initiatives in six states. Some of these documents address language access. More could be done, however, to pay for language access efforts. This article describes Medicaid ACO initiatives and explores how different payment tools could be leveraged to reward ACOs for increased access to care and quality language services. We find that a combination of payment tools might be helpful to encourage both access and quality.


PLOS ONE | 2013

Correction: Mouse Middle Ear Ion Homeostasis Channels and Intercellular Junctions

Lisa M. Morris; Jacqueline M. DeGagne; J. Beth Kempton; Frances A. Hausman; Dennis R. Trune

The version of Figure 1 that exists in the article is incorrect. The correct version can be found here:

Collaboration


Dive into the Lisa M. Morris's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge